3.93 USD
↗ 0.22 (6.04%)LIVE (AS OF 01:20 PM EST)
Oramed Pharmaceuticals Inc. (ORMP) trades at $3.93 per share. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Key drivers include a weak Piotroski F-Score of 0/9, exceptional Return on Equity (54.8%) and a bullish Golden Cross on the moving averages. On the valuation side, ORMP appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Nov 13, 2026.